NVZMY News and Press, Novozymes A/S ADR From 01/05/23

Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further...

Novozymes A/S (NVZMF) Q3 2022 Earnings Conference Call November 03, 2022 04:00 AM ET Company Participants Tobias Cornelius Bjorklund - Head-Investor Relations Ester Baiget - Chief Executive Officer Lars Green - Chief Financial Officer Tina Fanoe - Executive V...

The following slide deck was published by Novozymes A/S in conjunction with their 2022 Q3 earnings call. For further details see: Novozymes A/S 2022 Q3 - Results - Earnings Call Presentation

Summary The passing of the Queen has swiftly circled the globe. Now, King Charles holds the torch and has significant power over economies, especially if more hands on than his mother. Interestingly, an initiative already lays out some of the King's favorite holdings and offer...

The following slide deck was published by Novozymes A/S in conjunction with their 2022 Q1 earnings call. For further details see: Novozymes A/S 2022 Q1 - Results - Earnings Call Presentation

Novozymes A/S (NVZMF) Q2 2022 Earnings Conference Call August 11, 2022 03:00 AM ET Company Participants Tobias Bjorklund - Head of IR Ester Baiget - President and CEO Lars Green - Executive VP and CFO Anders Lund - EVP of Consumer Biosolutions Claus Fugls...

Novozymes A/S press release ( OTCPK:NVZMY ): 1H 10% organic sales growth. For FY22, organic sales growth outlook narrowed to 6%-8% from 4%-8%. For further details see: Novozymes A/S reports 1H results

Novozymes A/S (NVZMF) Q1 2022 Results Conference Call April 27, 2022 03:00 AM ET Company Participants Tobias Bjorklund - Head, IR Ester Baiget - CEO Lars Green - CFO Tina Fanoe - EVP, Agriculture & Industrial Biosolutions Amy Byrick - EVP, Strategy & Business Transformation Anders Lun...

Novozymes A/S press release (OTCPK:NVZMF): Q1 GAAP EPS of DKK2.98. Revenue of DKK4.37B (+15.6% Y/Y). For further details see: Novozymes A/S GAAP EPS of DKK2.98, revenue of DKK4.37B

Novozymes A/S (NVZMF) Q4 2021 Earnings Conference Call February 1, 2022, 03:00 AM ET Company Participants Tobias Bjorklund - Head of Investor Relations Ester Baiget - CEO Lars Green - Executive Vice President & CFO Tina Fanø - EVP, Agriculture & Industrial Biosolutions Anders Lun...